From: The role of optical coherence tomography guidance in scaffold versus stent optimization
 | BRS | DES | ||
---|---|---|---|---|
 | Odds ratio (95% CI) | p value | Odds ratio (95% CI) | p value |
Clinical presentation: | ||||
 CSA | 1.77 (0.9–3.48) | 0.095 | 1.02 (0.34–3.04) | 0.964 |
 UA | 1.34 (0.54–3.31) | 0.519 | 0.99 (0.21–4.59) | 0.99 |
 NSTEMI | 2.165 (1.03–4.52) | 0.04* | 0.42 (0.13–1.39) | 0.158 |
 Late/lysed MI | 0.7 (1.19–2.59) | 0.59 | – | – |
 Primary PCI | 2.2 (0.82–5.84) | 0.113 | 1.71 (0.22–13.08) | 0.603 |
 Silent ischemia | 0.45 (0.16–1.26) | 0.131 | 5.0 (0.88–28.33) | 0.069 |
Target vessel: | ||||
 LAD | 1.03 (0.57–1.87) | 0.911 | 2.18 (0.7–6.72) | 0.175 |
 LCX | 0.56 (0.25–1.21) | 0.144 | 0.76 (0.172–3.38) | 0.721 |
 RCA | 1.62 (0.815–3.24) | 0.168 | 0.63 (0.14–2.72) | 0.539 |
ACC/AHA B2/C | 1.82 (1.016–3.28) | 0.044* | 1.96 (0.63–6.07) | 0.239 |
Bifurcation stenting | 1.5 (0.57–3.95) | 0.407 | 2.93 (0.981–8.79) | 0.05* |
Moderate/severe calcification | 2.41 (1.407–4.15) | 0.001* | 1.30 (0.55–3.5) | 0.484 |
Overlap | 1.84 (1.09–3.08) | 0.021* | 1.56 (0.53–4.57) | 0.413 |
In-stent restenosis | 1.81 (0.62–5.27) | 0.272 | 1.9 (0.74–5.07) | 0.171 |
CTO | 0.65 (0.18–2.29) | 0.509 | 1.01 (0.08–11.76) | 0.988 |
Ostial | 0.65 (0.32–1.31) | 0.234 | 1.39 (0.55–3.52) | 0.484 |